Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy.
BJU Int
; 133(3): 297-304, 2024 Mar.
Article
in En
| MEDLINE
| ID: mdl-37548533
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Carcinoma, Renal Cell
/
HIV Infections
/
Hepatitis C
/
Kidney Neoplasms
Type of study:
Guideline
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
BJU Int
Journal subject:
UROLOGIA
Year:
2024
Type:
Article
Affiliation country:
United States